MMP1 and MMP9 can be used as independent prognostic factors to predict the prognosis of breast cancer patients, in order to further study the pathological mechanism and possible treatment targets for breast cancer, especially for Her2 and Basel subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.